Company Profile

SAB Biotherapeutics Inc
Profile last edited on: 12/2/2023      CAGE: 75DV9      UEI: JTN1DN4YZJ76

Business Identifier: Unleashing power of body’s native biological defense system to produce immunotherapies
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2100 East 54th Street North
Sioux Falls, SD 57104
   (605) 679-6982
Location: Single
Congr. District: 00
County: Minnehaha

Public Profile

SAB Biotherapeutics is a clinical-stage biopharmaceutical company structured around development of powerful and proprietary immunotherapeutic polyclonal human antibodies to treat and prevent infectious diseases, immune and autoimmune disorders and oncology. The firm's evelopment programs harness the body’s natural defense system to address infectious diseases resulting from outbreaks and pandemics, as well as immunological, gastroenterological, and respiratory diseases that have significant mortality and health impacts on immunocompromised patients. SAB’s novel drug development platform -- DiversitAb™ -- has the unique capability to generate large quantities of specifically targeted, high-potency polyclonal antibodies without the need for convalescent plasma or human donors. Over a span of two decades, the firm's founding scientists have optimized and advanced genetic engineering and antibody science to develop Transchromosomic cows (Tc Bovine™) that produce fully-human, highly-efficacious polyclonal antibodies. The Tc Bovine™ are a proprietary component of the firm's novel platform to address the emergence, mutation, and diversity of modern health challenges.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Eddie Sullivan -- Co-founder , President & CEO

  Christoph L Bausch -- Chief Operating Officer

  Russell P Beyer -- EVP & Chief Financial Officer

  Rick Finnegan -- Chief Business Officer Executive VP of Program Management

  Edward Hamilton -- Co-Founder and Executive Chair

  Jinan Jiao -- Former CSO

  Alexandra Kropotova -- Executive Vice President & Chief Medical Officer

  Tom Luke -- Chief Medical Officer

  Jerry Pommer -- Chief Compliance Officer

  Charles Randall Jr -- Chief Financial Officer, Executive VP Support Services

  Alexei Yurievitch Savinov

  Melissa Ullerich -- Chief Communications Officer Executive VP

  Hua Wu -- Senior VP, Vaccinology and Antibody Development